tradmap

ALB Financials Albemarle

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 10.4% per year over the past 5 years.
  • Operating margin has contracted, at -7.1% in the latest year.

Financial health

  • Total debt ($3.2B) exceeds cash ($1.6B); net debt is $1.6B.
  • Total debt has grown slower than revenue (-2.2% vs 10.4% per year).
  • Operating income covered interest expense -1.8× in the latest year, down from 6.9× 5 years ago.
  • Total debt is 11× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 27.5% of free cash flow.
  • The dividend has grown 3.3% per year over the past 5 years.
Revenue & net income
-$1B $4B $10B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-33% 4% 42% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$993M -$150M $692M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $2B $4B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$3B $178M $3B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $5.1B -$511M 13.0% -7.1% $692M $3.2B $1.6B
2024 $5.4B -$1.2B 1.2% -33.0% -$993M $3.5B $1.2B
2023 $9.6B $1.6B 12.3% 2.6% -$828M $4.2B $890M
2022 $7.3B $2.7B 42.0% 33.7% $651M $3.2B $1.5B
2021 $3.3B $124M 30.0% 24.0% -$609M $2.4B $439M
2020 $3.1B $376M 31.8% 16.2% -$52M $3.6B $747M
2019 $3.6B $533M 35.0% 18.6% -$132M $3.1B $613M
2018 $3.4B $694M 36.1% 27.0% -$154M $1.7B $555M
2017 $3.1B $55M 36.0% 18.6% -$14M $1.8B $1.1B
2016 $2.7B $644M 36.2% 22.4% $539M $2.4B $2.3B
2015 $335M $133M $3.8B $214M
2014 $133M $382M $3.3B $2.5B
2013 $413M $278M $1.1B $477M
2012 $312M $208M $699M $478M
2011 $392M $297M $764M $469M

Valuation over time

How the market has priced ALB against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 5.2 10.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 2.3 4.5 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.4 2.9 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is ALB growing its revenue and profit?

Over the past 5 years, Albemarle's revenue has grown 10.4% per year. These are computed facts, not advice.

How much debt does ALB have?

As of FY2025, Albemarle reported $3.2B of total debt against $1.6B of cash; operating income covered interest expense -1.8×.

What is ALB's profit margin?

In FY2025, gross margin was 13.0%, operating margin -7.1%, and net margin -9.9%.

What is ALB's P/E ratio?

As of Jun '26, Albemarle traded at a price-to-earnings ratio of about 8.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.